View in EDS

Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial: Effect of Ritlecitinib on Patient-Reported Hair Loss in Patients with Alopecia Areata: R. Sinclair et al

Saved in:
Bibliographic Details
Title: Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial: Effect of Ritlecitinib on Patient-Reported Hair Loss in Patients with Alopecia Areata: R. Sinclair et al
Authors: Sinclair, Rodney1, Mesinkovska, Natasha2, Mitra, Debanjali3, Wajsbrot, Dalia3, Law, Ernest H.3 ernest.law@pfizer.com, Wolk, Robert4, King, Brett5
Source: American Journal of Clinical Dermatology. Jan2025, Vol. 26 Issue 1, p109-119. 11p.
Database: Academic Search Ultimate
Description
ISSN:11750561
DOI:10.1007/s40257-024-00899-4